PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS
The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
26.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor. |
---|---|
AbstractList | The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor. |
Author | KAUPPINEN, SAKARI PETRI, ANDREAS LINDOW, MORTEN HAGEDORN, PETER |
Author_xml | – fullname: PETRI, ANDREAS – fullname: KAUPPINEN, SAKARI – fullname: LINDOW, MORTEN – fullname: HAGEDORN, PETER |
BookMark | eNqNyr8KwjAQgPEMOvjvHW6Xgq3U4tieSXNIcyU9BKdSJE6SFur7o4MP4PT9hm-tFnGMYaWk9Vw77oQQGi2WL2DYA1qNV3I1aGMIS7wDG2gIPYN3ZZJmGZCzVJGw774Ei7c9tKWQdtJt1fI5vOaw-3WjwGhBm4Rp7MM8DY8Qw7vXbVYUp_x8qNLjH8sHvJcw6Q |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | PROGNOSTISCHES VERFAHREN ZUR BEURTEILUNG DER ARZNEIMITTELWIRKSAMKEIT VON MICRO RNA-122 INHIBITOREN IN HCV+ PATIENTEN PROCÉDÉ PROGNOSTIQUE D'ÉVALUATION DE L'EFFICACITÉ D'INHIBITEURS MICRO RNA-122 EN HCV+ PATIENTS |
ExternalDocumentID | EP2776590B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP2776590B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:01:05 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP2776590B13 |
Notes | Application Number: EP20120784565 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161026&DB=EPODOC&CC=EP&NR=2776590B1 |
ParticipantIDs | epo_espacenet_EP2776590B1 |
PublicationCentury | 2000 |
PublicationDate | 20161026 |
PublicationDateYYYYMMDD | 2016-10-26 |
PublicationDate_xml | – month: 10 year: 2016 text: 20161026 day: 26 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | ROCHE INNOVATION CENTER COPENHAGEN A/S |
RelatedCompanies_xml | – name: ROCHE INNOVATION CENTER COPENHAGEN A/S |
Score | 3.0488937 |
Snippet | The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE |
Title | PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161026&DB=EPODOC&locale=&CC=EP&NR=2776590B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La4NAEB5C-ry1aUvTF3soXorUx8boIZS4arQQV8w2pKegRiEXExpL_35HSdJe2tswC8PuwDy-3ZlZgMeemphmXixkamZUpnqiyZaZKnJmaEpRoNNUk7pReBwa_ht9nfVmLVjuemGaOaFfzXBEtKgM7b1q_PX65xLLaWorN8_pElmrF08MHGmLjjF9QUwhOfbAjbjDmcQYUlIYD7R-3-hZio1A6aDOousx--7UrptS1r8jincGhxEKK6tzaOVlB07Y7uO1DhyPt-_dHThqCjSzDTK3Rri5ABHFfBTyiQgYGbvC5w5BKEeY7zLE4iOCqWfAhuydcI-gkmNO4nAoq5pGgtAP7EDweIIk8dn0iURDEbihmFwC8VzBfBk3Ot8rZe5G-yPpV9AuV2V-DYSmmrUocj1FFEBpsbDSPgIa1UoUJStSM-lC908xN_-s3cJprd3aaWvGHbSrj8_8HqNxlT40evwGHI-Gzg |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ409VFvWjXW5x4MF0MESikcGlMWKGhhCV0bPTVAIemFNhbj33cgbfWit8lsMtmdZB7f7swswH1PjnU9y-eiqqeqqHZjRTT0RBJTTZHyHJ2mHFeNwn6gua_q81vvrQGLbS9MPSf0qx6OiBaVor2Xtb9e_VxiWXVt5foxWSBr-eTwgSVs0DGmL4gpBMsc2CGzGBUoRUoIooHS72s9QzIRKO31q-G8VeY0NaumlNXviOIcw36IworyBBpZ0YYW3X681oZDf_Pe3YaDukAzXSNzY4TrU-BhxEYBm3CPEt_mLrMIQjlCXZsiFh8RTD09OqTvhDkElRwxEgVDUVYU4gWuZ3qcRRMkiUunDyQccs8O-OQMiGNz6oq40dlOKTM73B2pew7NYllkF0DURDHmedZNEAWoaj43kj4CGtmIJSnNEz3uQOdPMZf_rN1By-X-eDb2gpcrOKo0XTlwRbuGZvnxmd1gZC6T21qn35Nmibs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROGNOSTIC+METHOD+FOR+CHECKING+EFFICACY+OF+MICRO+RNA-122+INHIBITORS+IN+HCV%2B+PATIENTS&rft.inventor=PETRI%2C+ANDREAS&rft.inventor=KAUPPINEN%2C+SAKARI&rft.inventor=LINDOW%2C+MORTEN&rft.inventor=HAGEDORN%2C+PETER&rft.date=2016-10-26&rft.externalDBID=B1&rft.externalDocID=EP2776590B1 |